Panagora Asset Management Inc X4 Pharmaceuticals, Inc Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$4.53 - $6.45 $4,801 - $6,837	-1,060 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$6.49 - $9.56 $84,545 - $124,538	-13,027 Reduced 92.48%	1,060 $7,000
Q1 2021 May 12, 2021	SELL	$6.63 - $10.28 $348,134 - $539,792	-52,509 Reduced 78.85%	14,087 $121,000
Q4 2020 Feb 10, 2021	SELL	$5.41 - $7.4 $3,251 - $4,447	-601 Reduced 0.89%	66,596 $428,000
Q3 2020 Nov 13, 2020	BUY	$6.09 - $9.15 $93,664 - $140,727	15,380 Added 29.68%	67,197 $455,000
Q2 2020 Aug 12, 2020	BUY	$7.98 - $10.44 $323,134 - $422,746	40,493 Added 357.59%	51,817 $483,000
Q1 2020 May 14, 2020	BUY	$6.03 - $11.01 $65,359 - $119,337	10,839 Added 2234.85%	11,324 $113,000
Q3 2019 Nov 12, 2019	BUY	$11.06 - $15.75 $3,981 - $5,670	360 Added 288.0%	485 $6,000
Q2 2019 Aug 09, 2019	BUY	$12.57 - $21.67 $1,571 - $2,708	125 New	125 $2,000

99.6M

421K

80.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $21.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.